Can regional R&D clusters power Britain’s next growth chapter?

Mark Leaver explores how devolved R&D clusters can provide the bridge from prototype to commercial success


  • UK regional innovation clusters are attracting renewed attention, driving local economic growth through the £500 million Local Innovation Partnership Fund (LIPF), with key clusters across the UK.
  • You can find more programmes in your region through The UK Research and Innovation Strength in Places Fund.
  • Devolution will increasingly become a central political concept in the coming years; allowing R&D clusters to define and develop programmes grounded in the strengths of those regions.

The UK’s start-up ecosystem has long been strong at generating early-stage ideas. The harder challenge has been turning those ideas into businesses ready for investment. 

The journey from technological breakthrough to profitable commercial product remains perilously uncertain and unstable. Exciting prototypes may secure early-stage seed funding, but the path from proof-of-concept to a scalable, market-ready technology is far less supported. This scale gap is where promising innovation frequently stalls and risks the UK losing pace with international development.

In the creative technology sector, where advances in immersive media, AI, and real-time production are rapidly reshaping industries, the stakes are particularly high: teams are working on inherently experimental concepts and even the potential commercial opportunities themselves are often still emerging. Businesses working at the edge of emerging tech need time and real-world production environments to explore them properly, to turn possibility into tangible potential. 

Regional innovation clusters

This is where UK regional innovation clusters are attracting renewed attention, driving local economic growth through the £500 million Local Innovation Partnership Fund (LIPF), with key clusters across the UK. The aim is to provide the infrastructure, expertise and commercial collaborations that tech start-ups need during the most fragile stage of growth. 

Devolved funding models place resource and decision-making at a regional level and design investment specifically matched to local demand and opportunity. This is complemented by a collaborative cluster with local and national industry partners, alongside connections to universities and academic research, making funding more agile, continuous in nature, and responsive. The third pillar is providing accessible, high-quality facilities that allow companies to test out, refine, and scale their technologies in real-world scenarios. 

That continuity of innovation support allows SMEs to move beyond early prototypes and into the deeper work of refining technologies, identifying viable market segments and building the partnerships needed to deploy them at scale. 

Find regional innovation clusters on this map, broken down by sector.

Case study: MyWorld, West of England

As an example, MyWorld has developed a devolved R&D investment model for the West of England that is responsive to regional and sector priorities. The programme is grounded in the region’s existing strengths across natural history, animation and immersive technologies, alongside the internationally recognised research expertise of the region’s universities.

As with many start-ups or smaller companies looking to innovate for new markets, balancing client work and deadlines alongside research and development can be incredibly tricky, with the latter always at risk of being pushed back, in order to keep the cashflow coming through. 

Just as importantly, sustained R&D support through innovation clusters helps businesses develop the credibility and capabilities investors look for. Demonstrating working applications, validated use cases, industry collaboration and international exposure significantly strengthen a company’s ability to secure larger follow-on investment. Without that bridge, many incredible, industry-changing technologies simply wouldn’t reach the point where they can be backed by private capital.

A recent investor session in Bristol saw a cohort of regional creative technology companies, that have progressed through MyWorld, pitching to a series of venture capital firms. The pitching companies, working across areas including virtual production, interactive gaming, and audio technology were presenting fully developed products with clear commercial pathways for investment readiness. This addressed a major challenge for investors, who may be deterred from start-up investment because key risks have not yet been identified or addressed. The companies had been able to already test their IP, with links to academic research as well as real-world production use cases: effectively the model provides a pre-qualifier and this clearer pathway makes them more investable. 

You can find more programmes like MyWorld through The UK Research and Innovation Strength in Places Fund.

Devolution and the future

Devolution will increasingly become a central political concept in the coming years; allowing R&D clusters to define and develop programmes grounded in the strengths of those regions.

In an increasingly competitive global innovation economy, the UK cannot rely solely on breakthrough ideas. It must also build the infrastructure that allows those ideas to mature into world-leading businesses. Sustained, devolved R&D funding is a crucial part of that infrastructure. Designing agile programmes rooted in place ensures maximum return on investment. It gives innovative SMEs exactly the right the time, space and tools they need to define new markets, develop transformative technologies and ultimately compete on the international stage.

Mark Leaver is the head of business partnerships and inward investment at MyWorld.

Read more

R&D tax relief: how to make a successful claim – With R&D Tax Relief, the process that leads to a successful claim can be difficult, particularly when navigating through the hundreds of pages of HMRC’s submission requirements

R&D misclaims are a ‘hidden risk’ for investors – Hari Sandhu explains what’s at risk for investors with R&D misclaims and how to safeguard against these errors

Related Topics

R&D